Skip to main content Skip to main menu
University of Florida Health University of Florida
Connection Newsletter

FUNDING UPDATE

 Internal + Extramural

Please visit our website to find the complete and updated list of cancer-focused extramural funding opportunities or subscribe to UFHCC Opportunity to receive the weekly email.

Limited Opportunities

2022 Damon Runyon Clinical Investigator Award

LOI Due: 11/30/2021 | Full Application: 2/1/2022

Ocala Royal Dames Request for Proposal for Cancer Research

LOI Due: 12/10/2021 | Full Application: 2/28/2022

Mary Kay Ash Foundation:Innovative / Translational Cancer Research Grant

LOI Due: 12/17/2021 | Full Application: 2/4/2022

NCI Pathway to Independence Award for Outstanding Early Stage Postdoctoral Researchers (K99-R00 – Independent Clinical Trial Required) RFA-CA-21-061

LOI Due: 1/9/2022 | Application: 2/28/2022

Extramural Opportunities

Non-Limited Opportunities

National Cancer Institute (NCI)

The role of Epstein Barr Virus (EBV) infection in Non-Hodgkin Lymphoma (NHL) and Hodgkin disease (HD) development with or without and underlying HIV infection (U01 Clinical Trial Optional)

PAR-21-348 | Application: 12/15/2021

Division of Cancer Biology Multi-Consortia Coordinating Center (U24 Clinical Trial Not Allowed)

PAR-21-348 | Application: 12/15/2021

Clinical Sites for HIV/Cervical Cancer Prevention ‘CASCADE’ Clinical Trials Network (UG1 Clinical Trial Required)

RFA-CA-21-047 | Application: 12/28/2021

Coordinating Center for HIV/Cervical Cancer Prevention ‘CASCADE’ Clinical Trials Network (U24 Clinical Trial Required)

RFA-CA-21-045 | Application: 12/28/2021

Clinical Characterization of Cancer Therapy-induced Adverse Sequelae and Mechanism-based Interventional Strategies (R01 Clinical Trial Optional) 

PAR-21-329 | Application: 2/5/2022 

Tobacco Control Policies to Promote Health Equity (R01 Clinical Trial Optional)

PAR-20-302 | Application: 2/5/2022

Modulating Human Microbiome Function to Enhance Immune Responses Againes Cancer (R01 Clinical Trial Optional)

PAR-22-061 | Application: 2/5/2022

Research Specialist (Clinician Scientist) Award (R50 Clinical Trial Not Allowed)

PAR-21-306 | Application: 2/8/2022 

Utilizing the PLCO Biospecimens Resource to Bridge Gaps in Cancer Etiology and Early Detection Research (U01 Clinical Trial Not Allowed) 

PAR-21-330 | Application: 2/11/2022

Tobacco Control Policies to Promote Health Equity (R21 Clinical Trial Optional)
PAR-20-303 | Application: 2/16/2022

Modulating Human Microbiome Function to Enhance Immune Responses Against Cancer (R21 Clinical Trial Not Allowed)

PAR-22-062 | Application: 2/16/2022

Exploratory Grants in Cancer Control (R21 Clinical Trial Optional)

PAR-21-341 | Application: 6/7/2022

Department of Defense (DOD)

National Institutes of Health (NIH) 

HEAL Initiative: Advancing Health Equity in Pain Management (R61/R33 Clinical Trial Required)

RFA-NS-22-002 | Application: 12/9/2021

Research Infrastructure Development for Interdisciplinary Aging Studies (R21/R33 – Clinical Trial Optional)

PAR-20-070 | Application: 2/16/2022

New Investigators to Promote Workforce Diversity in Genomics, Bioinformatics, or Bioengineering and Biomedical Imaging Research (R01 Clinical Trial Optional)

RFA-HG-21-041 | Application: 2/22/2022 

Discovery of Genetic Basis of Childhood Cancers and of Structural Birth Defects: Gabriella Miller Kids First Pediatric Research Program (X01 Clinical Trial Not Allowed)

PAR-22-054 | Application: 2/28/2022

Research to Improve Native American Health (R21 Clinical Trials Optional) 

PAR-20-2014 | Application: 5/17/2022 

Intervention Research to Improve Native American Health (R01 Clinical Trial Optional)

PAR-20-238 | Application: 5/17/2022 

American Cancer Society 

The Role of Health Policy and Health Insurance in Improving Access to and Performance of Cancer Prevention, Early Detection, and Treatment Services 

Application: 4/1/2022 

Non-Peer Reviewed Agencies

Cancer Research Institute 

Clinic and Laboratory Integration Program (CLIP) 

LOI Deadline: 12/1/2021 

Lloyd J. Old STAR Program

Application: 1/15/2022

American Society of Clinical Oncology (ASCO)

ACRA for Diversity and Inclusion in Breast Cancer Research

LOI Deadline: 12/14/2021

Research Professorship for Diversity and Inclusion in Breast Cancer

LOI Deadline: 12/14/2021

Young Investigator Award

Application: 1/10/2022

Marsha Rivkin Center for Ovarian Cancer

Pilot Study Awards

Application: 12/1/2021

Scientific Scholar Awards

Application: 12/1/2021

Sigma Theta Tau International

Women’s Oncology, and Pediatrics Research Award

Application: 12/1/2021

Morris Animal Foundation

Call for Studies Addressing Limb-Sparing Treatments for Osteosarcoma in Saint Bernards and Other Giant-Breed Dogs

Application: 1/14/2022

Conquer Cancer

Lobular Breast Cancer Alliance Young Investigator Award

Application: 1/10/2022

Damon Runyon Cancer Research Foundation

Physician-Scientist Training Award

Application: 12/1/2021

The Florida Breast Cancer Foundation

Scientific Research Grants

Application: 12/10/2021